Evidence map›Paper›PMID 35958595›Full record

ArticleFrontiers in immunology2022

Combining segments 9 and 10 in DNA and recombinant protein vaccines conferred superior protection against tilapia lake virus in hybrid red tilapia (

Pitakthai Chamtim, Eukote Suwan, Ha Thanh Dong, Soranuth Sirisuay, Nontawith Areechon, Eakapol Wangkahart, Ikuo Hirono, Rapeepat Mavichak, Sasimanas Unajak

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Pitakthai ChamtimDepartment of Biochemistry, Faculty of Science, Kasetsart University, Bangkok, Thailand.
Eukote SuwanFaculty of Veterinary Technology, Kasetsart University, Bangkok, Thailand.
Ha Thanh DongAquaculture and Aquatic Resources Management Program, Department of Food, Agriculture and Bioresources (AARM/FAB), School of Environment, Resources and Development, Asian Institute of Technology, Pathum Thani, Thailand.
Soranuth SirisuayDepartment of Aquaculture, Faculty of Fisheries, Kasetsart University, Bangkok, Thailand.
Nontawith AreechonDepartment of Aquaculture, Faculty of Fisheries, Kasetsart University, Bangkok, Thailand.
Eakapol WangkahartDivision of Fisheries, Department of Agricultural Technology, Faculty of Technology, Mahasarakham University, Maha Sarakham, Thailand.
Ikuo HironoGraduate School of Marine Science and Technology, Tokyo University of Marine Science and Technology, Tokyo, Japan.
Rapeepat MavichakMolecular Biology Research Department, Charoen Pokphand Foods Public Co., Ltd., Aquatic Animal Health Research Center, Samut Sakhon, Thailand.
Sasimanas UnajakDepartment of Biochemistry, Faculty of Science, Kasetsart University, Bangkok, Thailand.
Kasetsart University · THAsian Institute of Technology · THCharoenkrung Pracharak Hospital · THMahasarakham University · THTokyo University of Marine Science and Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tilapia lake virus (TiLV) now affects Nile tilapia culture worldwide, with no available commercial vaccine for disease prevention. DNA and recombinant protein-based vaccines were developed and tested following viral isolation and characterization. The viral strain isolated from diseased hybrid red tilapia (

Indexed as

CichlidsFish DiseasesTilapiaVirusesAnimalsDNAVaccines, SyntheticDNAVaccines, SyntheticDNA vaccinerecombinant protein vaccinetilapia (fish)TiLVTiLV ORF10TiLV ORF9

Identifiers

PMID35958595
PMCPMC9359061
OpenAlexW4287378006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.